Shopping Cart 0
Cart Subtotal
AED 0

Oxford Immunotec Ltd - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec's T-SPOT solution offers diagnosing disease by measuring immune response to an infection. The company offers laboratories services such as oxford diagnostics. It operates in the US, the UK, Japan, South Korea and China. Oxford Immunotec is headquartered in Abingdon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Oxford Immunotec Ltd Company Overview

Oxford Immunotec Ltd Company Snapshot

Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview

Oxford Immunotec Ltd-Pipeline Analysis Overview

Oxford Immunotec Ltd-Key Facts

Oxford Immunotec Ltd-Major Products and Services

Oxford Immunotec Ltd Pipeline Products by Development Stage

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Oxford Immunotec Ltd Pipeline Products Overview

B Cell ELISPOT Assay

B Cell ELISPOT Assay Product Overview

ELISPOT Tumor Assay

ELISPOT Tumor Assay Product Overview

ELISPOT Tumor Assay Clinical Trial

I-O Monitoring Test

I-O Monitoring Test Product Overview

Metabovis Assay-Homocysteine

Metabovis Assay-Homocysteine Product Overview

Risk Stratification System-Kidney Transplantation

Risk Stratification System-Kidney Transplantation Product Overview

SpiroFind

SpiroFind Product Overview

Stratokine

Stratokine Product Overview

T-Cell Select

T-Cell Select Product Overview

T-SPOT.ICA

T-SPOT.ICA Product Overview

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease Product Overview

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease Product Overview

Oxford Immunotec Ltd-Key Competitors

Oxford Immunotec Ltd-Key Employees

Oxford Immunotec Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Oxford Immunotec Ltd, Recent Developments

Aug 06, 2019: Oxford Immunotec reports second quarter 2019 financial results

Jun 24, 2019: Oxford Immunotec appoints Patrick J. Balthrop, Sr. as Chairman

May 17, 2019: Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel

May 09, 2019: Oxford Immunotec reports first quarter 2019 financial results

Mar 28, 2019: Oxford Immunotec announces new initiative to bring the benefit of modern tuberculosis testing to the Russian Federation

Mar 21, 2019: Oxford Immunotec announces Chief Financial Officer transition

Mar 11, 2019: Oxford Immunotec reports fourth quarter and full year 2018 financial results

Nov 09, 2018: Oxford Immunotec announces third quarter 2018 financial results

Jul 31, 2018: Oxford Immunotec reports second quarter 2018 financial results

Jun 05, 2018: Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT.TB Test

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oxford Immunotec Ltd Pipeline Products by Equipment Type

Oxford Immunotec Ltd Pipeline Products by Development Stage

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview

Oxford Immunotec Ltd Pipeline Products by Equipment Type

Oxford Immunotec Ltd Pipeline Products by Indication

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Oxford Immunotec Ltd, Key Facts

Oxford Immunotec Ltd, Major Products and Services

Oxford Immunotec Ltd Number of Pipeline Products by Development Stage

Oxford Immunotec Ltd Pipeline Products Summary by Development Stage

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Oxford Immunotec Ltd Ongoing Clinical Trials Summary

B Cell ELISPOT Assay-Product Status

B Cell ELISPOT Assay-Product Description

ELISPOT Tumor Assay-Product Status

ELISPOT Tumor Assay-Product Description

ELISPOT Tumor Assay-da VINci Study (OTSGC-A24 Therapeutic Peptide Vaccine + Ipilimumab + Nivolumab) Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer-A Combination Immunotherapy Phase Ib Study

I-O Monitoring Test-Product Status

I-O Monitoring Test-Product Description

Metabovis Assay-Homocysteine-Product Status

Metabovis Assay-Homocysteine-Product Description

Risk Stratification System-Kidney Transplantation-Product Status

Risk Stratification System-Kidney Transplantation-Product Description

SpiroFind-Product Status

SpiroFind-Product Description

Stratokine-Product Status

Stratokine-Product Description

T-Cell Select-Product Status

T-Cell Select-Product Description

T-SPOT.ICA-Product Status

T-SPOT.ICA-Product Description

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease-Product Status

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease-Product Description

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease-Product Status

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease-Product Description

Oxford Immunotec Ltd, Key Employees

Oxford Immunotec Ltd, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Oxford Immunotec Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

AorTech International Plc

Arcomedical Infusion Ltd

CME Medical UK Ltd

Summary

Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec's T-SPOT solution offers diagnosing disease by measuring immune response to an infection. The company offers laboratories services such as oxford diagnostics. It operates in the US, the UK, Japan, South Korea and China. Oxford Immunotec is headquartered in Abingdon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Oxford Immunotec Ltd Company Overview

Oxford Immunotec Ltd Company Snapshot

Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview

Oxford Immunotec Ltd-Pipeline Analysis Overview

Oxford Immunotec Ltd-Key Facts

Oxford Immunotec Ltd-Major Products and Services

Oxford Immunotec Ltd Pipeline Products by Development Stage

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Oxford Immunotec Ltd Pipeline Products Overview

B Cell ELISPOT Assay

B Cell ELISPOT Assay Product Overview

ELISPOT Tumor Assay

ELISPOT Tumor Assay Product Overview

ELISPOT Tumor Assay Clinical Trial

I-O Monitoring Test

I-O Monitoring Test Product Overview

Metabovis Assay-Homocysteine

Metabovis Assay-Homocysteine Product Overview

Risk Stratification System-Kidney Transplantation

Risk Stratification System-Kidney Transplantation Product Overview

SpiroFind

SpiroFind Product Overview

Stratokine

Stratokine Product Overview

T-Cell Select

T-Cell Select Product Overview

T-SPOT.ICA

T-SPOT.ICA Product Overview

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease Product Overview

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease Product Overview

Oxford Immunotec Ltd-Key Competitors

Oxford Immunotec Ltd-Key Employees

Oxford Immunotec Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Oxford Immunotec Ltd, Recent Developments

Aug 06, 2019: Oxford Immunotec reports second quarter 2019 financial results

Jun 24, 2019: Oxford Immunotec appoints Patrick J. Balthrop, Sr. as Chairman

May 17, 2019: Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel

May 09, 2019: Oxford Immunotec reports first quarter 2019 financial results

Mar 28, 2019: Oxford Immunotec announces new initiative to bring the benefit of modern tuberculosis testing to the Russian Federation

Mar 21, 2019: Oxford Immunotec announces Chief Financial Officer transition

Mar 11, 2019: Oxford Immunotec reports fourth quarter and full year 2018 financial results

Nov 09, 2018: Oxford Immunotec announces third quarter 2018 financial results

Jul 31, 2018: Oxford Immunotec reports second quarter 2018 financial results

Jun 05, 2018: Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT.TB Test

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oxford Immunotec Ltd Pipeline Products by Equipment Type

Oxford Immunotec Ltd Pipeline Products by Development Stage

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview

Oxford Immunotec Ltd Pipeline Products by Equipment Type

Oxford Immunotec Ltd Pipeline Products by Indication

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Oxford Immunotec Ltd, Key Facts

Oxford Immunotec Ltd, Major Products and Services

Oxford Immunotec Ltd Number of Pipeline Products by Development Stage

Oxford Immunotec Ltd Pipeline Products Summary by Development Stage

Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Oxford Immunotec Ltd Ongoing Clinical Trials Summary

B Cell ELISPOT Assay-Product Status

B Cell ELISPOT Assay-Product Description

ELISPOT Tumor Assay-Product Status

ELISPOT Tumor Assay-Product Description

ELISPOT Tumor Assay-da VINci Study (OTSGC-A24 Therapeutic Peptide Vaccine + Ipilimumab + Nivolumab) Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer-A Combination Immunotherapy Phase Ib Study

I-O Monitoring Test-Product Status

I-O Monitoring Test-Product Description

Metabovis Assay-Homocysteine-Product Status

Metabovis Assay-Homocysteine-Product Description

Risk Stratification System-Kidney Transplantation-Product Status

Risk Stratification System-Kidney Transplantation-Product Description

SpiroFind-Product Status

SpiroFind-Product Description

Stratokine-Product Status

Stratokine-Product Description

T-Cell Select-Product Status

T-Cell Select-Product Description

T-SPOT.ICA-Product Status

T-SPOT.ICA-Product Description

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease-Product Status

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease-Product Description

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease-Product Status

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease-Product Description

Oxford Immunotec Ltd, Key Employees

Oxford Immunotec Ltd, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Oxford Immunotec Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

AorTech International Plc

Arcomedical Infusion Ltd

CME Medical UK Ltd